GlassScriptPhysician profile
Rahul Singh
NPI 1659535193
$2,848.38
in general payments reported to CMS, 2019-2025
18 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2022: $712 · 2023: $1,009 · 2024: $635 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,175 · Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,174.51 |
| Food and Beverage | $764.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,102.86 | 2019-2023 | Da Vinci Surgical System |
| Apollo Endosurgery US INC | $547.28 | 2022 | |
| Globus Medical, INC. | $276.36 | 2024 | |
| Baxter Healthcare | $180.62 | 2024 | Floseal, Peri-Strips Dry |
| Boston Scientific Corporation | $163.57 | 2019-2024 | Avvigo Guidance System |
| Innocoll Pharmaceuticals Limited | $125.00 | 2022 | |
| Novo Nordisk INC | $125.00 | 2025 | Wegovy |
| Abbott Laboratories | $110.41 | 2025 | Amplatzer Amulet |
| Merck Sharp & Dohme LLC | $79.90 | 2022-2025 | Keytruda, Keytruda Qlex |
| Ferring Pharmaceuticals INC. | $21.19 | 2019 | |
| Verastem, INC. | $20.24 | 2019 | |
| Endo Pharmaceuticals INC. | $18.26 | 2023 | Nascobal |
| Covidien LP | $16.67 | 2019 | |
| W. L. Gore & Associates, INC. | $14.79 | 2024 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Teleflex LLC | $14.27 | 2025 | Titan Sgs Bailout Chuck |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.06 | 2019 | |
| Olympus America INC. | $13.45 | 2024 | Single Use Repositionable Clip |
| Intra-Sana Laboratories | $4.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.